| 注册
首页|期刊导航|中国实用内科杂志|促骨形成药物的合理应用

促骨形成药物的合理应用

林滢 侯建明

中国实用内科杂志2025,Vol.45Issue(8):648-651,4.
中国实用内科杂志2025,Vol.45Issue(8):648-651,4.DOI:10.19538/j.nk2025080105

促骨形成药物的合理应用

Reasonable application of anabolic bone agents

林滢 1侯建明1

作者信息

  • 1. 福建省立医院福州大学附属省立医院内分泌科,福建 福州 350001
  • 折叠

摘要

Abstract

In recent years,the incidence of osteoporosis has increased yearly and it has emerged as a global public health issue.However,public awareness of osteoporosis is significantly insufficient.Complications such as fragility fractures seriously damage patients'quality of life and increase associated healthcare expenditures.Osteoporosis is preventable and treatable.Initiating appropriate therapeutic strategies requires comprehensive assessment of bone mineral density(BMD)and individualized fracture risk.For patients with imminent risk of fracture,the administration of anabolic bone agents enables rapid and effective achievement of therapeutic goals.

关键词

骨质疏松症/脆性骨折/骨折风险分层/促骨形成药物

Key words

osteoporosis/fragility fractures/fracture risk stratification/anabolic bone agents

分类

医药卫生

引用本文复制引用

林滢,侯建明..促骨形成药物的合理应用[J].中国实用内科杂志,2025,45(8):648-651,4.

基金项目

国家自然科学基金(82270934) (82270934)

中国实用内科杂志

OA北大核心

1005-2194

访问量0
|
下载量0
段落导航相关论文